Clinical Trial Update: Effects of N-acetyl Cysteine During Percutaneous Coronary Intervention [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effects of N-acetylcysteine during percutaneous coronary intervention in coronary artery disease is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Suleyman Demirel University | Conditions: Coronary Artery Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING